Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FBY24
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,252
Award facts
- Contract value 100% obligated
- $40,252.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,252.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for pharmaceutical products and supplies to be delivered to Conshohocken, Pennsylvania, with completion by November 25, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The DLA Troop Support Medical contract enables AmerisourceBergen to serve key customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a primary supplier within the agency's pharmaceutical distribution network. The Defense Logistics Agency is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, potentially diversifying the vendor base while maintaining AmerisourceBergen's significant role in federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DU26FBY24?
SPE2DU26FBY24 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DU26FBY24 worth?
The government has obligated $40,252 on SPE2DU26FBY24.
Is contract SPE2DU26FBY24 an order under another contract?
Yes. SPE2DU26FBY24 is a delivery order under SPE2DU25D1011, an indefinite delivery contract.
Was contract SPE2DU26FBY24 competed?
The extent of competition for SPE2DU26FBY24 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award